Bottom line
What does PJP hold?
PJP held 33 positions as of Jul 31, 2026. Its largest holding is Invesco Private Prime Fund at 7.93% of the fund, and the top 10 positions add up to 53.7%. By asset type it is 100% stocks, 12% cash & short-term funds.
Updated Sep 28, 2026
PJP top 25 holdings
| # | Holding | Type | % of fund | Value |
|---|---|---|---|---|
| 1 | Invesco Private Prime Fund | Cash & short-term funds | 7.93% | $37.4M |
| 2 | Abbott Laboratories | Stocks | 5.67% | $26.8M |
| 3 | AbbVie Inc. | Stocks | 5.48% | $25.9M |
| 4 | Amgen Inc. | Stocks | 5.33% | $25.2M |
| 5 | Johnson & Johnson | Stocks | 5.18% | $24.4M |
| 6 | Merck & Co., Inc. | Stocks | 5.06% | $23.9M |
| 7 | Eli Lilly and Co. | Stocks | 5.02% | $23.7M |
| 8 | Corcept Therapeutics Inc. | Stocks | 4.96% | $23.4M |
| 9 | Gilead Sciences, Inc. | Stocks | 4.53% | $21.4M |
| 10 | Pfizer Inc. | Stocks | 4.50% | $21.2M |
| 11 | Amneal Pharmaceuticals, Inc. | Stocks | 3.75% | $17.7M |
| 12 | Invesco Private Government Fund | Cash & short-term funds | 3.73% | $17.6M |
| 13 | Liquidia Corp. | Stocks | 3.66% | $17.3M |
| 14 | Travere Therapeutics, Inc. | Stocks | 3.30% | $15.6M |
| 15 | Ligand Pharmaceuticals Inc. | Stocks | 3.20% | $15.1M |
| 16 | Regeneron Pharmaceuticals, Inc. | Stocks | 3.14% | $14.8M |
| 17 | Harmony Biosciences Holdings, Inc. | Stocks | 3.06% | $14.5M |
| 18 | Bristol-Myers Squibb Co. | Stocks | 2.94% | $13.9M |
| 19 | Viatris Inc. | Stocks | 2.83% | $13.3M |
| 20 | Jazz Pharmaceuticals PLC | Stocks | 2.79% | $13.2M |
| 21 | Biogen Inc. | Stocks | 2.75% | $13.0M |
| 22 | Collegium Pharmaceutical, Inc. | Stocks | 2.74% | $12.9M |
| 23 | Prestige Consumer Healthcare Inc. | Stocks | 2.74% | $12.9M |
| 24 | Ocular Therapeutix, Inc. | Stocks | 2.58% | $12.2M |
| 25 | ANI Pharmaceuticals, Inc. | Stocks | 2.55% | $12.0M |
Source: SEC Form N-PORT, period ended Jul 31, 2026, filed Sep 28, 2026